471 related articles for article (PubMed ID: 21453258)
1. Nanocrystal technology in the delivery of poorly soluble drugs: an overview.
Nagarwal RC; Kumar R; Dhanawat M; Das N; Pandit JK
Curr Drug Deliv; 2011 Jul; 8(4):398-406. PubMed ID: 21453258
[TBL] [Abstract][Full Text] [Related]
2. Nanocrystal for ocular drug delivery: hope or hype.
Sharma OP; Patel V; Mehta T
Drug Deliv Transl Res; 2016 Aug; 6(4):399-413. PubMed ID: 27165145
[TBL] [Abstract][Full Text] [Related]
3. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives.
Shegokar R; Müller RH
Int J Pharm; 2010 Oct; 399(1-2):129-39. PubMed ID: 20674732
[TBL] [Abstract][Full Text] [Related]
4. Progress in the study of drug nanocrystals.
Shi J; Guo F; Zheng A; Zhang X; Sun J
Pharmazie; 2015 Dec; 70(12):757-64. PubMed ID: 26817271
[TBL] [Abstract][Full Text] [Related]
5. Application of drug nanocrystal technologies on oral drug delivery of poorly soluble drugs.
Gao L; Liu G; Ma J; Wang X; Zhou L; Li X; Wang F
Pharm Res; 2013 Feb; 30(2):307-24. PubMed ID: 23073665
[TBL] [Abstract][Full Text] [Related]
6. Polymeric formulations for drug release prepared by hot melt extrusion: application and characterization.
Stanković M; Frijlink HW; Hinrichs WL
Drug Discov Today; 2015 Jul; 20(7):812-23. PubMed ID: 25660507
[TBL] [Abstract][Full Text] [Related]
7. Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process.
Abuzar SM; Hyun SM; Kim JH; Park HJ; Kim MS; Park JS; Hwang SJ
Int J Pharm; 2018 Mar; 538(1-2):1-13. PubMed ID: 29278733
[TBL] [Abstract][Full Text] [Related]
8. Contribution of hot-melt extrusion technology to advance drug delivery in the 21st century.
Tiwari RV; Patil H; Repka MA
Expert Opin Drug Deliv; 2016; 13(3):451-64. PubMed ID: 26886062
[TBL] [Abstract][Full Text] [Related]
9. Lipid nanoparticles for the delivery of poorly water-soluble drugs.
Bunjes H
J Pharm Pharmacol; 2010 Nov; 62(11):1637-45. PubMed ID: 21039547
[TBL] [Abstract][Full Text] [Related]
10. Nano-formulations of drugs: Recent developments, impact and challenges.
Jeevanandam J; Chan YS; Danquah MK
Biochimie; 2016; 128-129():99-112. PubMed ID: 27436182
[TBL] [Abstract][Full Text] [Related]
11. Nanocrystal: a novel approach to overcome skin barriers for improved topical drug delivery.
Patel V; Sharma OP; Mehta T
Expert Opin Drug Deliv; 2018 Apr; 15(4):351-368. PubMed ID: 29465253
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical nanocrystals: production by wet milling and applications.
Malamatari M; Taylor KMG; Malamataris S; Douroumis D; Kachrimanis K
Drug Discov Today; 2018 Mar; 23(3):534-547. PubMed ID: 29326082
[TBL] [Abstract][Full Text] [Related]
13. Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs.
Liu Y; Liang Y; Yuhong J; Xin P; Han JL; Du Y; Yu X; Zhu R; Zhang M; Chen W; Ma Y
Drug Des Devel Ther; 2024; 18():1469-1495. PubMed ID: 38707615
[TBL] [Abstract][Full Text] [Related]
14. Production of nanosuspensions as a tool to improve drug bioavailability: focus on topical delivery.
Lai F; Schlich M; Pireddu R; Corrias F; Fadda AM; Sinico C
Curr Pharm Des; 2015; 21(42):6089-103. PubMed ID: 26503149
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical solid dispersion technology: a strategy to improve dissolution of poorly water-soluble drugs.
Kumar S; Gupta SK
Recent Pat Drug Deliv Formul; 2013 Aug; 7(2):111-21. PubMed ID: 23331062
[TBL] [Abstract][Full Text] [Related]
16. Cyclodextrin-Based Formulations: A Non-Invasive Platform for Targeted Drug Delivery.
Muankaew C; Loftsson T
Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):46-55. PubMed ID: 29024354
[TBL] [Abstract][Full Text] [Related]
17. Nanocrystals Technology for Transdermal Delivery of Water-Insoluble Drugs.
Liu Y; Zhao J; Wang L; Yan B; Gu Y; Chang P; Wang Y
Curr Drug Deliv; 2018; 15(9):1221-1229. PubMed ID: 29779482
[TBL] [Abstract][Full Text] [Related]
18. Nanocrystals Technology for Pharmaceutical Science.
Cheng Z; Lian Y; Kamal Z; Ma X; Chen J; Zhou X; Su J; Qiu M
Curr Pharm Des; 2018; 24(21):2497-2507. PubMed ID: 29773056
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles: A personal experience for formulating poorly water soluble drugs.
Cooper ER
J Control Release; 2010 Feb; 141(3):300-2. PubMed ID: 19822177
[TBL] [Abstract][Full Text] [Related]
20. Formation, characterization, and fate of inhaled drug nanoparticles.
Zhang J; Wu L; Chan HK; Watanabe W
Adv Drug Deliv Rev; 2011 May; 63(6):441-55. PubMed ID: 21118707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
